Shionogi Group (Shionogi & Co. Ltd and its affiliated companies, collectively “Shionogi”) has Shionogi’s Company Policy, which was first instituted in 1957, which sets forth the purpose of Shionogi’s corporate activities as being “to strive constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve”.
As a responsible, growing company, Shionogi recognizes that a robust compliance framework is an essential component in achieving its business objectives. To this end, all of Shionogi’s officers and employees strive to maintain and improve compliance through raising their internal awareness. This is grounded in the principle of not only acting in compliance with relevant laws, rules and regulations in the territories in which Shionogi operates, but also considering and understanding the ethical and societal impact of Shionogi’s actions.
Reflecting Shionogi’s commitment towards compliance, Shionogi has implemented the following fundamental tax policy globally.